GENELUX CORP
GNLX·36870H103·US·Common Stock·Healthcare - Biotechnology-13D/G
GNLX (GENELUX CORP) is held by 38 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($5M), BlackRock, Inc. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($1.3M). Net institutional sentiment: Mixed.
38
Holders
(2 Elite)
$13.3M
Total Value
50% (34)
Consensus
17 buying - 17 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Sep 18, 2026 · Insiders Sep 2, 2026 · Activists Feb 17, 2026 · Congress none
InsiderCJCappello JosephSell $28KAug 31, 2026
InsiderZTZindrick ThomasSell $92KAug 31, 2026
InsiderYYYu YongSell $27KAug 31, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 41
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer